Status:
RECRUITING
Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia
Lead Sponsor:
Shanghai East Hospital
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
40+ years
Phase:
NA
Brief Summary
This trial is comparing the effects and safety in treating men with benign prostatic hyperplasia between high freqnence irreversible electroporation and trans urethral resection prostate.
Detailed Description
A Prospective, Single-center, Randomized Controlled Trial Comparing the Efficacy and Safety of High-Frequency Irreversible Electroporation and Trans Urethral Resection Prostate for Benign Prostatic Hy...
Eligibility Criteria
Inclusion
- Age over 40 years old
- IPSS\>8
- Qmax \<15ml/s
- Prostatic volume range of 30 to 100ml, measured by MRI
- Fully understand the clinical trial protocol and sign the informed consent
Exclusion
- Have a history of prostate cancer or patients suspicious of prostate cancer Neurogenic bladder Metal implants in their body Previous history of prostatic or urethral surgery With Catheterisation more than 2 weeks Any other conditions that investigator judges that participations who are not suitable for this trial
Key Trial Info
Start Date :
June 30 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
118 Patients enrolled
Trial Details
Trial ID
NCT05306145
Start Date
June 30 2022
End Date
April 1 2026
Last Update
November 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Haifeng Wang
Shanghai, China